Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03287817
Title CD19/22 CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma (ALEXANDER)
Acronym ALEXANDER
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Autolus Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR


No variant requirements are available.